ijms-logo

Journal Browser

Journal Browser

Integrated Approaches, Molecular Mechanism and Therapies in Ocular Surface Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 25 March 2025 | Viewed by 168

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medicine and Surgery, University of Enna “Kore”, Piazza dell'Università, 94100 Enna (EN), Italy
Interests: glaucoma; clinical ophthalmology; retinal diseases; inflammation; immunology of infectious diseases; OCT; macular degeneration; eye diseases; corneal diseases; ocular surface; dry eye diseases; retinal degeneration; inherited retinal disorders; rare ophthalmic diseases

E-Mail Website
Guest Editor
Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy
Interests: clinical ophthalmology; glaucoma; tonometry; ocular hypertension; visual field testing; OCT; pachymetry; refractive errors; cornea; dry eye disorders; stem cells; corneal wound lesions; ocular surface; lid diagnostics and treatments
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Eye Clinic, Public Health Department, University of Naples Federico II, 80131 Naples, Italy
Interests: cataract surgery; ocular trauma management; vitreoretinal surgery; experimental ocular surgery; 3D surgery; secondary IOL implantation; pole-to-pole surgery

Special Issue Information

Dear Colleagues,

We are pleased to host a Special Issue entitled “Integrated Approaches, Molecular Mechanism and Therapies in Ocular Surface Diseases”. This Special Issue seeks to investigate the novel applications of blood-derived products in the treatment and management of ocular surface diseases. We welcome submissions from top scholars, clinicians, and healthcare professionals who are pioneers in their fields. This issue will cover a wide range of topics, including the molecular and cellular mechanisms, clinical applications, and outcomes of using autologous serum, platelet-rich plasma, umbilical cord derivatives, and other novel blood-based therapies to treat conditions such as dry eye syndrome, corneal ulcers, and persistent epithelial defects.

Our goal is to create a complete collection of original research articles, reviews, and case studies that demonstrate the efficacy and safety of these treatments, as well as their integration into established therapy procedures. This special issue aims to expand our understanding and application of blood component therapy in ophthalmology by bringing together varied perspectives and discoveries. In addition, our goal is to explore the molecular processes by which these medicines are derived from blood exercise and their effects on illnesses of the ocular surface. This Special Issue will enhance our comprehension of how these medicines might be optimized for clinical use by examining the fundamental biological processes and their therapeutic consequences.

We welcome papers that shed light on patient selection, treatment methods, and long-term outcomes, as well as those that investigate the molecular mechanisms underlying the healing benefits of these therapies. This is a great opportunity to contribute to a growing field of study with important clinical consequences, and we look forward to receiving your valuable submissions.

Prof. Dr. Caterina Gagliano
Dr. Marco Zeppieri
Prof. Dr. Mario Damiano Toro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

 

Keywords

  • ocular surface diseases
  • dry eye
  • corneal ulcers
  • persistent epithelial defects
  • blood-derived products
  • blood-based therapies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop